Not applicableStudy completedNCT04072159What this trial is testingCommunity Pharmacists Vaccinate Against CancerWho this might be right forHuman Papillomavirus Vaccines Arizona State University 33
Not applicableLooking for participantsNCT07358910What this trial is testingRisk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health PerspectiveWho this might be right forDengueChikungunyaZika Virus Infection+55 more Institut Pasteur du Cambodge 10,000
Large-scale testing (Phase 3)Study completedNCT04782895What this trial is testingImmunogenicity of a Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58)Vaccine(E.Coli) Versus Gardasil®9 in Healthy Females 18-26 Years of AgeWho this might be right forCervical CancerCondylomata Acuminata Xiamen University 488
Not applicableUnknownNCT01427777What this trial is testing3-year Immunogenicity Evaluation of Quadrivalent HPV Vaccine in ChinaWho this might be right forAnogenital Human Papilloma Virus Infection Guangxi Center for Disease Control and Prevention 300
Large-scale testing (Phase 3)Active Not RecruitingNCT04534205What this trial is testingA Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1Who this might be right forUnresectable Head and Neck Squamous Cell CarcinomaMetastatic Head and Neck CancerRecurrent Head and Neck Cancer BioNTech SE 358
Large-scale testing (Phase 3)Study completedNCT00518180What this trial is testingEvaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In AdolescentsWho this might be right forMeningococcal MeningitisHuman Papillomavirus InfectionPertussis+1 more Novartis Vaccines 1,620
Large-scale testing (Phase 3)Study completedNCT01456715What this trial is testingImmunogenicity of Gardasil and Twinrix and the Effect of a Dose of Gardasil or Cervarix Given 42 Months Later.Who this might be right forHuman Papillomavirus Laval University 418
Large-scale testing (Phase 3)Looking for participantsNCT05027776What this trial is testingImmunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 YearsWho this might be right forHPV InfectionsCervical Cancer Stage IIaVaginal Cancer+4 more Shanghai Bovax Biotechnology Co., Ltd. 1,348
Large-scale testing (Phase 3)Study completedNCT01190176What this trial is testingGynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study SubjectsWho this might be right forInfections, Papillomavirus GlaxoSmithKline 34
Not applicableUnknownNCT01300689What this trial is testingHuman Papillomavirus Infection and Knowledge and Attitudes About HPV Vaccines Among Men Who Have Sex With Men (MSM)Who this might be right forHPV InfectionHIV InfectionSyphilis Chinese Academy of Medical Sciences 3,000
Large-scale testing (Phase 3)Ended earlyNCT05584332What this trial is testingA Phase Ⅲ Study to Evaluate the Efficacy, Immunogenicity, Safety of Quadrivalent HPV Recombinant Vaccine in Chinese Healthy FemalesWho this might be right forCervical CancerGenital WartCIN1+9 more Shanghai Bovax Biotechnology Co., Ltd. 3,131
Not applicableStudy completedNCT06702423What this trial is testingAI Chatbot for HPV Vaccine Literacy Among Caregivers in JapanWho this might be right forHealthy The University of Hong Kong 804
Testing effectiveness (Phase 2)Study completedNCT00513526What this trial is testingHuman Papillomavirus Vaccine Therapy in Treating Men With HIV-1 InfectionWho this might be right forInfectionPrecancerous Condition AIDS Malignancy Consortium 112
Large-scale testing (Phase 3)Not Yet RecruitingNCT07785843What this trial is testingA Clinical Study of V503 in Chinese Females Who Have Previously Received a Bivalent Human Papillomavirus (HPV) Vaccine (V503-108)Who this might be right forPapillomavirus Infections Merck Sharp & Dohme LLC 930
Very early researchStudy completedNCT01568515What this trial is testingElectronic Messaging to Increase Human Papillomavirus Vaccine Utilization and Adherence Among College StudentsWho this might be right forPatient ComplianceHealth Knowledge, Attitudes, Practice East Carolina University 283
Not applicableActive Not RecruitingNCT06587243What this trial is testing"Facts Tell… and With Stories Sell?" Combining Viewer-tailored Personal Human Papillomavirus (HPV) Narrative Video With HPV Vaccine Information Video to Improve HPV Vaccine UptakeWho this might be right forVaccination Johns Hopkins Bloomberg School of Public Health 1,100
Early research (Phase 1)Study completedNCT00667563What this trial is testingVaccine Therapy in Preventing HPV in HIV-Positive Women in IndiaWho this might be right forCervical CancerNonneoplastic ConditionPrecancerous Condition AIDS Malignancy Consortium 150
Not applicableUnknownNCT01314404What this trial is testingKAP/WTP and HPV Prevalence Studies in a Developing World Setting (Bamako, Mali)Who this might be right forHuman Papillomavirus Global Alliance to Immunize Against AIDS Vaccine Foundation 460
Testing effectiveness (Phase 2)Study completedNCT05694728What this trial is testingA Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV VaccineWho this might be right forHuman Papilloma Virus Infection Beijing Health Guard Biotechnology, Inc 780
Large-scale testing (Phase 3)Study completedNCT00316706What this trial is testingHuman Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 VaccineWho this might be right forCervical Intraepithelial NeoplasiaPapillomavirus Infection GlaxoSmithKline 1,245